Nuez-Martínez, M, Queralt-Martín M, Muñoz-Juan A, Aguilella {VM }, Laromaine A, Teixidor F, Viñas C, Pinto {CG }, Pinheiro T, Guerreiro {JF }, Mendes F, Roma-Rodrigues C, Baptista {PV}, Fernandes {AR}, Valic S, Marques F.
2022.
Boron clusters (ferrabisdicarbollides) shaping the future as radiosensitizers for multimodal (chemo/radio/PBFR) therapy of glioblastoma, dec. Journal of Materials Chemistry B. 10:9794–9815., Number 47: RSC - Royal Society of Chemistry
AbstractGlioblastoma multiforme (GBM) is the most common and fatal primary brain tumor, and is highly resistant to conventional radiotherapy and chemotherapy. Therefore, the development of multidrug resistance and tumor recurrence are frequent. Given the poor survival with the current treatments, new therapeutic strategies are urgently needed. Radiotherapy (RT) is a common cancer treatment modality for GBM. However, there is still a need to improve RT efficiency, while reducing the severe side effects. Radiosensitizers can enhance the killing effect on tumor cells with less side effects on healthy tissues. Herein, we present our pioneering study on the highly stable and amphiphilic metallacarboranes, ferrabis(dicarbollides) ([o-FESAN]− and [8,8′-I2-o-FESAN]−), as potential radiosensitizers for GBM radiotherapy. We propose radiation methodologies that utilize secondary radiation emissions from iodine and iron, using ferrabis(dicarbollides) as iodine/iron donors, aiming to achieve a greater therapeutic effect than that of a conventional radiotherapy. As a proof-of-concept, we show that using 2D and 3D models of U87 cells, the cellular viability and survival were reduced using this treatment approach. We also tested for the first time the proton boron fusion reaction (PBFR) with ferrabis(dicarbollides), taking advantage of their high boron (11B) content. The results from the cellular damage response obtained suggest that proton boron fusion radiation therapy, when combined with boron-rich compounds, is a promising modality to fight against resistant tumors. Although these results are encouraging, more developments are needed to further explore ferrabis(dicarbollides) as radiosensitizers towards a positive impact on the therapeutic strategies for GBM.
Santos, MFA, Sciortino G, Correia I, Fernandes ACP, Santos-Silva T, Pisanu F, Garribba E, Pessoa JC.
2022.
Binding of VIVO2+, VIVOL, VIVOL2 and VVO2L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications, 2022. Chemistry – A European JournalChemistry – A European Journal. 28(40):e202200105.: John Wiley & Sons, Ltd
AbstractAbstract Vanadium compounds have frequently been proposed as therapeutics, but their application has been hampered by the lack of information on the different V-containing species that may form and how these interact with blood and cell proteins, and with enzymes. Herein, we report several resolved crystal structures of lysozyme with bound VIVO2+ and VIVOL2+, where L=2,2?-bipyridine or 1,10-phenanthroline (phen), and of trypsin with VIVO(picolinato)2 and VVO2(phen)+ moieties. Computational studies complete the refinement and shed light on the relevant role of hydrophobic interactions, hydrogen bonds, and microsolvation in stabilizating the structure. Noteworthy is that the trypsin?VVO2(phen) and trypsin?VIVO(OH)(phen) adducts correspond to similar energies, thus suggesting a possible interconversion under physiological/biological conditions. The obtained data support the relevance of hydrolysis of VIV and VV complexes in the several types of binding established with proteins and the formation of different adducts that might contribute to their pharmacological action, and significantly widen our knowledge of vanadium?protein interactions.
Isufi, B, Relvas JP, Marchão C, Ramos A.
2022.
Behavior of flat slabs with partial use of high-performance fiber reinforced concrete under monotonic vertical loading. Engineering Structures. 264(August 2022):114471.
AbstractReinforced concrete flat slabs are used worldwide in multi-story buildings. In these slabs, the design is often governed by punching shear and serviceability. The mitigation of these issues during design usually leads to increased raw material consumption and costs. Previous studies have shown that using Fiber Reinforced Concrete (FRC) or High-Strength Concrete (HSC) only at the vicinity of the column, while casting the rest of the slab with Normal Strength Concrete (NSC), can lead to an improved behavior under gravity loads in terms of both serviceability and ultimate capacity. Motivated by these results and the scarcity of previous tests, the present paper experimentally investigates the applicability of High-Performance Fiber Reinforced Concrete (HPFRC) as an alternative material that can be seen as an improvement over FRC and HSC, allowing a combination of ductility and strength. In addition, the HPFRC used in this paper is self-compacting, thus reducing the labor costs associated with concrete vibration. Five 150 mm thick flat slabs were tested under monotonically increasing punching load. The experimental variables were the flexural reinforcement ratio and the extent of the HPFRC zone. One of the specimens was cast only with NSC and served as a reference slab. Results show that the solution was effective for both flexural reinforcement ratios considered. Cracking load, maximum load, as well as the displacement capacity were increased significantly, even for a small extent of HPFRC (1.5 times the effective depth from the face of the column). Regarding the ultimate load capacity, it was observed an increase of 44% to 58% for the specimens with lower reinforcement ratio (0.64%) and between 15%–21% for the specimens with higher reinforcement ratio (0.96%). The results indicate that the use of HPFRC is a promising solution regarding both serviceability and ultimate limit state design of reinforced concrete flat slabs under gravity loading, with obvious advantages in material savings and labor costs.